Premia China STAR50 ETF (03151.HK) Rises 5.41% in Afternoon Trade, Turnover Reaches HKD 7.4120 Million
NewTimeSpace News: As of August 5 at 13:39, Premia China STAR50 ETF (03151.HK) rose 5.41%, with a latest price of HKD 12.080, an opening price of HKD 11.800, a high of HKD 12.090, a low of HKD 11.610, and an intraday amplitude of 4.19%. The ETF traded 621,400 shares, with a turnover of HKD 7.4120 Million and an average price of HKD 11.928. The premium rate is 0.36%, with a turnover rate of 0.83%. The current Net Asset Value (NAV) is HKD 11.419, with Assets Under Management (AUM) of HKD 857 Million, total outstanding shares of 75.00 Million, and a lot size of 200 shares.
Premia China STAR50 ETF (03151.HK) closely tracks the SSE Science and Technology Innovation Board 50 Component Index (STAR 50). The manager of the fund is Premia Partners Company Limited. The investment objective of the Sub-Fund is to provide investment results closely tracking the performance of the SSE Science and Technology Innovation Board 50 Component Index (the "Index") before deduction of fees and expenses.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- CMOC (03993.HK): A-share buyback of RMB 1-2 billion, cap RMB 22.78
- HOPE LIFE INT (01683.HK): Wu Yifan Appointed Executive Director
- TIME INTERCON (01729.HK): 24-Month Buyback of Up to HKD500 Million
- HUANENG POWER (00902.HK): Huaneng Coal Power REIT Lists in Shanghai
- CSPC PHARMA (01093.HK): SYS6055 In Vivo CAR-T Trial Starts